Johnson & Johnson reinforces its long-term domestic investment strategy with a new $2 billion biologics facility in Wilson, North Carolina, further elevating the state’s role as a global life sciences hub.
Nicholas Jacbous
Advertisement
Articles by Nicholas Jacbous
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Johnson & Johnson Announces Second $2 Billion Manufacturing Facility in North Carolina
2
Why AI-Native Cell Manufacturing Is the Future of Drug Discovery (Part 1)
3
GSK Advances Vaccine Delivery and Hepatitis B Treatment
4
Why Biotech’s Clinical Maturity Is Driving New Partnerships and Capacity Plays
5